Login

Arjan Meijer Discusses New Embraer Turboprop | Arjan Meijer - CEO of Embraer 00:10:00

Share On Facebook Share On Twitter

Arjan Meijer is Pres/CEO:Commercial Aviation at Embraer SA.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Buchan Wealth Management Limited and Bouchey Financial Group, Ltd. are distinct entities renowned for their expertise in personalized wealth management strategies.
00:10:00
Al Gore's Insights on Climate Action and Democracy | Al Gore , Chairman , Generation Investment Management.
00:10:00
Aims to support early-stage companies that are working to solve important healthcare needs|Andy Schwab,Managing Partner,5AM Ventures
00:00:00
Steven Lydeamore Chief Executive Officer, Immuron Ltd
00:10:00
The 3 Tax Traps Physicians Should Avoid: Expert Tips from Scott Sturgeon | Scott Sturgeon, Founder, Oread Wealth Partners.
00:10:00
Go-VX Uranium Focuses on Developing Permitted Projects in Africa
00:10:00
Evaluating the Risk Dynamics of High-Risk Mutual Fund Categories | Nimesh Shah, CEO , ICICI Prudential Mutual Fund .
00:10:00
Unveiling the Potential of Basin Gulch: Lannister Mining's Journey
00:10:00
Insights into Venture Capital with Bill Comfort
00:10:00
Benoit Grossmann Discusses Venture Capital Dynamics at Idinvest | Benoist Grossmann, Managing Partner, Idinvest Partners.
00:00:00
Biophytis sees positive data from PHASE 2-3 COVA CLINICAL STUDY of Sarconeos - Stanislas Veillet , CEO, Biophytis
00:10:00
Nick Bolton, CEO of Oxford Metrics, discusses the company's earnings and growth in augmented and virtual reality technologies.|Imogen was appointed CEO of Oxford Metrics

© 2026 Nehu